1. Chemotherapy in metastatic castration-resistant prostate cancer: Current scenario and future perspectives
    Vicenç Ruiz de Porras et al, 2021, Cancer Letters CrossRef
  2. Shikonin Reduces Growth of Docetaxel-Resistant Prostate Cancer Cells Mainly through Necroptosis
    Sascha D. Markowitsch et al, 2021, Cancers CrossRef
  3. Shikonin potentiates paclitaxel antitumor efficacy in esophageal cancer cells via the apoptotic pathway
    Wenzhen Du et al, 2019, Oncology Letters CrossRef
  4. Characterization of the Anti-Cancer Activity of the Probiotic Bacterium Lactobacillus fermentum Using 2D vs. 3D Culture in Colorectal Cancer Cells
    null Lee et al, 2019, Biomolecules CrossRef
  5. Targeting the stress oncoprotein LEDGF/p75 to sensitize chemoresistant prostate cancer cells to taxanes
    Leslimar Ríos-Colón et al, 2017, Oncotarget CrossRef
  6. CD34 and Bcl-2 as predictors for the efficacy of neoadjuvant chemotherapy in cervical cancer
    Yun Lin et al, 2021, Archives of Gynecology and Obstetrics CrossRef
  7. Targeting the androgen receptor (AR) with AR degradation enhancer ASC-J9® led to increase docetaxel sensitivity via suppressing the p21 expression
    Jie Luo et al, 2019, Cancer Letters CrossRef
  8. Quantify the effect of docetaxel with different concentration on cell mechanical properties using atomic force microscopy
  9. Knockdown of lncRNA TUG1 attenuates cerebral ischemia/reperfusion injury through regulating miR ‐142‐3p
    Leibing Li et al, 2021, BioFactors CrossRef
  10. Disulfiram potentiates docetaxel cytotoxicity in breast cancer cells through enhanced ROS and autophagy
    K. Laxmi Swetha et al, 2020, Pharmacological Reports CrossRef
  11. Solid state fermentation process with Aspergillus kawachii enhances the cancer-suppressive potential of silkworm larva in hepatocellular carcinoma cells
    Hyun-Dong Cho et al, 2019, BMC Complementary and Alternative Medicine CrossRef
  12. Oral exposure of sulpiride promotes the proliferation of Brown‑Norway rat prostates
    Chengcheng Zheng et al, 2020, Experimental and Therapeutic Medicine CrossRef
  13. The Role of BCL-2 Proteins in the Development of Castration-resistant Prostate Cancer and Emerging Therapeutic Strategies
    Luke Soliman et al, 2021, American Journal of Clinical Oncology CrossRef
  14. Docetaxel suppresses immunotherapy efficacy of natural killer cells toward castration‐resistant prostate cancer cells via altering androgen receptor‐lectin‐like transcript 1 signals
    Min Tang et al, 2020, The Prostate CrossRef
  15. Oncolytic adenovirus carrying SPAG9-shRNA enhanced the efficacy of docetaxel for advanced prostate cancer
    Meng Lu et al, 2022, Anti-Cancer Drugs CrossRef
  16. Auriculasin-induced ROS causes prostate cancer cell death via induction of apoptosis
    Hyun-Dong Cho et al, 2018, Food and Chemical Toxicology CrossRef
  17. Preclinical Study Using ABT263 to Increase Enzalutamide Sensitivity to Suppress Prostate Cancer Progression Via Targeting BCL2/ROS/USP26 Axis Through Altering ARv7 Protein Degradation
    Hua Xu et al, 2020, Cancers CrossRef
  18. Suppression of GLI sensitizes medulloblastoma cells to mitochondria-mediated apoptosis
    Zhongxiao Lin et al, 2016, Journal of Cancer Research and Clinical Oncology CrossRef
  19. Nanoparticles from Gantrez® AN-poly(ethylene glycol) conjugates as carriers for oral delivery of docetaxel
    Luisa Ruiz-Gatón et al, 2019, International Journal of Pharmaceutics CrossRef
  20. Mechanisms of Taxane Resistance
    Sara M. Maloney et al, 2020, Cancers CrossRef
  21. Taxane-based Combination Therapies for Metastatic Prostate Cancer
    Paul G. Corn et al, 2019, European Urology Focus CrossRef
  22. Omentin protects H9c2 cells against docetaxel cardiotoxicity
    Ricardo Lage et al, 2019, PLOS ONE CrossRef
  23. A landmark in drug discovery based on complex natural product synthesis
    Satoshi Kawano et al, 2019, Scientific Reports CrossRef
  24. FAM3B/PANDER inhibits cell death and increases prostate tumor growth by modulating the expression of Bcl-2 and Bcl-XL cell survival genes
    Paula Maciel-Silva et al, 2018, BMC Cancer CrossRef